Type 1 Diabetes

Dermatologic complications of diabetes devices may impact long-term outcomes in pediatric patients

Dermatologic complications associated with continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) devices, such as contact dermatitis and lipodystrophies, can negatively impact glycemic control and adherence, particularly in pediatric patients with type 1 diabetes, according to a study. Researchers reviewed 25 studies, supplemented by 5 additional articles, focusing...